BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23937701)

  • 1. Detectable urogenital schistosome DNA and cervical abnormalities 6 months after single-dose praziquantel in women with Schistosoma haematobium infection.
    Downs JA; Kabangila R; Verweij JJ; Jaka H; Peck RN; Kalluvya SE; Changalucha JM; Johnson WD; van Lieshout L; Fitzgerald DW
    Trop Med Int Health; 2013 Sep; 18(9):1090-1096. PubMed ID: 23937701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of praziquantel drug against Schistosoma haematobium and performance of urine reagent strips among pre-and-school aged children during the high transmission season in North-Western Tanzania.
    Mazigo HD; Kayange N; Ambrose EE; Zinga MM; Mugassa S; Ruganuza D; Mwingira UJ; Uisso C; Mutapi F
    Acta Trop; 2024 Aug; 256():107232. PubMed ID: 38729329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community.
    Adewale B; Mafe MA; Sulyman MA; Idowu ET; Ajayi MB; Akande DO; Mckerrow JH; Balogun EO
    Korean J Parasitol; 2018 Dec; 56(6):577-581. PubMed ID: 30630278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.
    Zinyama-Gutsire R; Gomo E; Kallestrup P; Erikstrup C; Ullum H; Butterworth AE; Munyati S; Mduluza T
    BMC Infect Dis; 2009 Oct; 9():174. PubMed ID: 19852800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy.
    Ouedraogo H; Drabo F; Zongo D; Bagayan M; Bamba I; Pima T; Yago-Wienne F; Toubali E; Zhang Y
    Bull World Health Organ; 2016 Jan; 94(1):37-45. PubMed ID: 26769995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
    Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
    PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of Schistosoma real-time PCR in urine samples from Kenyan children infected with Schistosoma haematobium: day-to-day variation and follow-up after praziquantel treatment.
    Vinkeles Melchers NV; van Dam GJ; Shaproski D; Kahama AI; Brienen EA; Vennervald BJ; van Lieshout L
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2807. PubMed ID: 24743389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen.
    Darko SN; Hanson H; Twumasi-Ankrah S; Baffour-Awuah S; Adjei-Kusi P; Yar D; Owusu-Dabo E
    BMC Infect Dis; 2020 May; 20(1):323. PubMed ID: 32375658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
    Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
    Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
    Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping Schistosoma haematobium for Novel Interventions against Female Genital Schistosomiasis and Associated HIV Risk in KwaZulu-Natal, South Africa.
    Livingston M; Pillay P; Zulu SG; Sandvik L; Kvalsvig JD; Gagai S; Galappaththi-Arachchige HN; Kleppa E; Ndhlovu P; Vennervald B; Gundersen SG; Taylor M; Kjetland EF
    Am J Trop Med Hyg; 2021 May; 104(6):2055-2064. PubMed ID: 33939629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of an imported case of schistosomiasis haematobium].
    Yan-Rong L; Han-Guo X; Zhu-Yun C; Li-Zhen X; Rong-Yan Z
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2017 Jan; 29(1):108-110. PubMed ID: 29469403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endemic status of urogenital schistosomiasis and the efficacy of a single-dose praziquantel treatment in unmapped rural farming communities in Oyo East Local Government Area, Oyo State, Nigeria.
    Odaibo AB; Komolafe AK; Olajumoke TO; Diyan KD; Aluko DA; Alagbe OA; Ajagbe OA; Olarinloye DB
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012101. PubMed ID: 38620032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe.
    Midzi N; Sangweme D; Zinyowera S; Mapingure MP; Brouwer KC; Kumar N; Mutapi F; Woelk G; Mduluza T
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):759-66. PubMed ID: 18486169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
    Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of genital cervical schistosomiasis: comparison of cytological, histopathological and parasitological examination.
    Poggensee G; Sahebali S; Van Marck E; Swai B; Krantz I; Feldmeier H
    Am J Trop Med Hyg; 2001 Sep; 65(3):233-6. PubMed ID: 11561710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.